Status:
COMPLETED
Motion Sickness Rehabilitation for Virtual Reality
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Motion Sickness
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study was to investigate the effect of a rehabilitation program on motion sickness. A combined rehabilitation program will be given participants who showed motion sickness sympto...
Detailed Description
In the realm of virtual environments and simulators, a significant hurdle that hampers user engagement resides in the manifestation of adverse effects. These deleterious consequences become apparent d...
Eligibility Criteria
Inclusion
- having stereoacuity score of 3552 arc/s on the Titmus Fly Test
Exclusion
- having partial or total vision loss
- being diagnosed with vertigo
- having previous experience of head mounted virtual reality devices
Key Trial Info
Start Date :
December 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT06056622
Start Date
December 4 2022
End Date
May 15 2023
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abant Izzet Baysal University
Bolu, Merkez, Turkey (Türkiye), 14100